Novavax's total assets for Q1 2025 were $1.29B, a decrease of -17.14% from the previous quarter. GB:0A3S total liabilities were $1.37B for the fiscal quarter, a -37.34% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.